BioWorld MedTech

Dec. 23, 2013

View Archived Issues

Israel's ICI Conference describes major Digital Health 'Apportunity'

FDA/CMS extend parallel review program for two more years

Report from Europe: Baxter receives CE mark for VIVIA HD System

FINANCINGS ROUNDUP: Oracle Investment Management to purchase 12.1M shares of Vermillion

PEOPLE IN PLACES:

PRODUCT BRIEFS:

Keeping you up to date on recent developments in neurology

CFDA streamlines domestic medicaldevice re-registration requirements

Looking to help the domestic device industry continue to grow, China's regulator has issued new regulations for the registration of new products from the beginning of 2014. Read More

Tryton Medical launches its Bifurcation Institute

Today's news in brief

BioWorld

BioWorld briefs for May 22, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

Genescience presents STAT6 degrader for atopic dermatitis

BioWorld Science

Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....

Roche reports new TREM2 agonists

BioWorld Science

F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...